These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 32522388)

  • 1. Reply to Benjamin S. Simpson, Lina M. Carmona Echeverria, Joseph M. Norris, Hashim U. Ahmed, Caroline M. Moore, and Hayley C. Whitaker's Letter to the Editor re: Gregory T. Chesnut, Emily A. Vertosick, Nicole Benfante, et al. Role of Changes in Magnetic Resonance Imaging or Clinical Stage in Evaluation of Disease Progression for Men with Prostate Cancer on Active Surveillance. Eur Urol 2020;77:501-7.
    Chesnut GT; Vickers AJ; Ehdaie B
    Eur Urol; 2020 Sep; 78(3):e108-e109. PubMed ID: 32522388
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to Jianhui Du, Yueguang Liu, and Weigang Yan's Letter to the Editor re: Gregory T. Chesnut, Emily A. Vertosick, Nicole Benfante, et al. Role of Changes in Magnetic Resonance Imaging or Clinical Stage in Evaluation of Disease Progression for Men with Prostate Cancer on Active Surveillance. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.12.009.
    Chesnut GT; Vertosick EA; Ehdaie B
    Eur Urol; 2020 Aug; 78(2):e65-e66. PubMed ID: 32386781
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Gregory T. Chesnut, Emily A. Vertosick, Nicole Benfante, et al. Role of Changes in Magnetic Resonance Imaging or Clinical Stage in Evaluation of Disease Progression for Men with Prostate Cancer on Active Surveillance. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.12.009.
    Du J; Liu Y; Yan W
    Eur Urol; 2020 Aug; 78(2):e64. PubMed ID: 32362499
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Gregory T. Chesnut, Emily A. Vertosick, Nicole Benfante, et al. Role of Changes in Magnetic Resonance Imaging or Clinical Stage in Evaluation of Disease Progression for Men with Prostate Cancer on Active Surveillance. Eur Urol 2020;77:501-7.
    Simpson BS; Carmona Echeverria LM; Norris JM; Ahmed HU; Moore CM; Whitaker HC
    Eur Urol; 2020 Sep; 78(3):e106-e107. PubMed ID: 32527691
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply to Won Ho Kim, Hyun-Kyu Yoon, Chang Wook Jeong's Letter to Editor re: Carlo Bravi, Emily Vertosick, Nicole Benfante, et al. Impact of Acute Kidney Injury, Its Duration on Long-term Renal Function After Partial Nephrectomy. Eur Urol 2019;76:398-403.
    Bravi CA
    Eur Urol; 2020 Jan; 77(1):e16-e17. PubMed ID: 31590938
    [No Abstract]   [Full Text] [Related]  

  • 6. Reply to Carissa E. Chu, Peter E. Lonergan, and Peter R. Carroll's Letter to the Editor re: Vasilis Stavrinides, Francesco Giganti, Bruce Trock, et al. Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort Study. Eur Urol 2020;78:443-51.
    Stavrinides V; Giganti F; Emberton M; Moore CM
    Eur Urol; 2020 Sep; 78(3):e112-e113. PubMed ID: 32653326
    [No Abstract]   [Full Text] [Related]  

  • 7. Reply to Francesco Montorsi, Giorgio Gandaglia, Nicola Fossati, Andrea Salonia, and Alberto Briganti's Letter to the Editor re: Vasilis Stavrinides, Francesco Giganti, Bruce Trock, et al. Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort Study. Eur Urol 2020;78:443-51.
    Stavrinides V; Giganti F; Emberton M; Moore CM
    Eur Urol; 2020 Oct; 78(4):e166. PubMed ID: 32712048
    [No Abstract]   [Full Text] [Related]  

  • 8. Reply to Yaalini Shanmugabavan, Stephanie Guillaumier and Hashim U. Ahmed's letter to the editor re: Morgan R. Pokorny, Maarten de Rooij, Earl Duncan, et al. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies. Eur Urol 2014;66:22-9.
    Pokorny M; Van de Ven W; Barentsz J; Thompson L
    Eur Urol; 2015 Mar; 67(3):e54-5. PubMed ID: 25194908
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Carlo Bravi, Emily Vertosick, Nicole Benfante, et al. Impact of Acute Kidney Injury and Its Duration on Long-term Renal Function After Partial Nephrectomy. Eur Urol 2019;76:398-403.
    Kim WH; Yoon HK; Jeong CW
    Eur Urol; 2020 Jan; 77(1):e14-e15. PubMed ID: 31586511
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: Vasilis Stavrinides, Francesco Giganti, Bruce Trock, et al. Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort Study. Eur Urol 2020;78:443-51.
    Chu CE; Lonergan PE; Carroll PR
    Eur Urol; 2020 Sep; 78(3):e110-e111. PubMed ID: 32622551
    [No Abstract]   [Full Text] [Related]  

  • 11. Re: Vasilis Stavrinides, Francesco Giganti, Bruce Trock, et al. Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort Study. Eur Urol 2020;78:443-51.
    Montorsi F; Gandaglia G; Fossati N; Salonia A; Briganti A
    Eur Urol; 2020 Oct; 78(4):e165. PubMed ID: 32798145
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply to Diana A. Castillo-Jimenez and Herney A. García-Perdomo's Letter to the Editor re: Niranjan J. Sathianathen, Badrinath R. Konety, Fernando Alarid-Escudero, Nathan Lawrentschuk, Damien M. Bolton, Karen M. Kuntz. Cost-effectiveness Analysis of Active Surveillance Strategies for Men with Low-risk Prostate Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2018.10.055. Standardized Reporting for Economic Analyses Should be Mandatory.
    Sathianathen NJ; Konety BR
    Eur Urol; 2019 Jul; 76(1):e10-e11. PubMed ID: 30665809
    [No Abstract]   [Full Text] [Related]  

  • 13. Reply to Emily Vertosick and Andrew Vickers' letter to the editor re: Alberto Briganti, Thomas Wiegel, Steven Joniau, et al. early salvage radiation therapy does not compromise cancer control in patients with pT3N0 Prostate cancer after radical prostatectomy: results of a match-controlled multi-institutional analysis. Eur Urol 2012;62:472-87.
    Briganti A
    Eur Urol; 2013 Apr; 63(4):e51-2. PubMed ID: 23305881
    [No Abstract]   [Full Text] [Related]  

  • 14. Reply to Massimo Valerio, Mark Emberton, and Hashim U. Ahmed's Letter to the Editor re: Henk G. van der Poel, Roderick C.N. van den Bergh, Erik Briers, et al. Focal Therapy in Primary Localised Prostate Cancer: The European Association of Urology Position in 2018. Eur Urol 2018;74:84-91.
    van der Poel HG; van den Bergh RCN; Briers E; Cornford P; Govorov A; Henry AM; Lam TB; Mason MD; Rouvière O; De Santis M; Wiegel T; Willemse PM; van Poppel H; Mottet N
    Eur Urol; 2019 Feb; 75(2):e23-e24. PubMed ID: 30237024
    [No Abstract]   [Full Text] [Related]  

  • 15. Re: Role of Changes in Magnetic Resonance Imaging or Clinical Stage in Evaluation of Disease Progression for Men with Prostate Cancer on Active Surveillance.
    Llorente C
    Eur Urol; 2020 Jun; 77(6):756-757. PubMed ID: 32173127
    [No Abstract]   [Full Text] [Related]  

  • 16. Re: Hashim U. Ahmed, Louise Dickinson, Susan Charman, et al. Focal Ablation Targeted to the Index Lesion in Multifocal Localised Prostate Cancer: a Prospective Development Study. Eur Urol 2015;68:927-36.
    Li H; Yan W; Ji Z
    Eur Urol; 2016 Nov; 70(5):e131. PubMed ID: 27085626
    [No Abstract]   [Full Text] [Related]  

  • 17. Re: Long-Term Outcomes of Active Surveillance for Prostate Cancer: The Memorial Sloan Kettering Cancer Center ExperienceSigrid Carlsson, Nicole Benfante, Ricardo Alvim, Daniel D. Sjoberg, Andrew Vickers, Victor E. Reuter, Samson W. Fine, Hebert Alberto Vargas, Michal Wiseman, Maha Mamoor, Behfar Ehdaie, Vincent Laudone, Peter Scardino, James Eastham and Karim Touijer
    Montorsi F; Gandaglia G; Fossati N; Briganti A
    J Urol; 2021 Feb; 205(2):340-341. PubMed ID: 33035136
    [No Abstract]   [Full Text] [Related]  

  • 18. Reply to Arnaldo Stanzione, Massimo Imbriaco, and Renato Cuocolo's Letter to the Editor re: Marloes van der Leest, Bas Israël, Eric Bastiaan Cornel, et al. High Diagnostic Performance of Short Magnetic Resonance Imaging Protocols for Prostate Cancer Detection in Biopsy-naïve Men: The Next Step in Magnetic Resonance Imaging Accessibility. Eur Urol 2019;76:574-81. Are We Meeting Our Standards? Stringent Prostate Imaging Reporting and Data System Acquisition Requirements Might be Limiting Prostate Accessibility.
    Leest MV; Israël B; Engels RRM; Barentsz JO
    Eur Urol; 2020 Mar; 77(3):e58-e59. PubMed ID: 31818520
    [No Abstract]   [Full Text] [Related]  

  • 19. Reply to Erik Rud, Peter Lauritzen, and Eduard Baco's Letter to the Editor re: Henrik Grönberg, Martin Eklund, Wolfgang Picker, et al. Prostate Cancer Diagnostics Using a Combination of the Stockholm3 Blood Test and Multiparametric Magnetic Resonance Imaging. Eur Urol 2018;74:722-8.
    Eklund M; Ström P; Grönberg H; Nordström T
    Eur Urol; 2019 Apr; 75(4):e104-e105. PubMed ID: 30514569
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: Risk of Metastasis in Men with Grade Group 2 Prostate Cancer Managed with Active Surveillance at a Tertiary Cancer CenterS. Carlsson, N. Benfante, R. Alvim, D. D. Sjoberg, A. Vickers, V. E. Reuter, S. W. Fine, H. A. Vargas, M. Wiseman, M. Mamoor, B. Ehdaie, V. Laudone, P. Scardino, J. Eastham and K. Touijer
    Shah N; Ioffe V
    J Urol; 2020 Nov; 204(5):1063-1064. PubMed ID: 32698711
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.